Related Experiment Video
Updated: Oct 15, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
957
A pharmacist-physician collaborative care model in chronic kidney disease
Hanlin Li1, Jai Radhakrishnan2
1Lead Clinical Pharmacy Manager, Ambulatory Care, Department of Pharmacy, NewYork-Presbyterian Hospital, New York, New York, USA.
Journal of Clinical Hypertension (Greenwich, Conn.)
|October 26, 2021
Summary
Pharmacist-led medication management, in collaboration with nephrologists and using technology, significantly improved diabetes and hypertension control in Chronic Kidney Disease (CKD) patients. This approach enhanced clinical outcomes for patients with suboptimal disease control.
Area of Science:
- Nephrology
- Clinical Pharmacy
- Health Services Research
Background:
- Chronic kidney disease (CKD) management requires a multidisciplinary approach.
- Pharmacist interventions are proven to improve clinical outcomes and reduce costs in chronic disease management.
- Integrating technology can further enhance patient care and outcomes.
Purpose of the Study:
- To describe the first study incorporating pharmacist-driven medication management with nephrologists for CKD patients.
- To evaluate the impact of a collaborative drug therapy management agreement on hypertension and diabetes mellitus control in CKD.
- To assess the role of technology in achieving therapeutic goals within this population.
Main Methods:
- A collaborative drug therapy management agreement was established between pharmacists and nephrologists.
- Patient referrals focused on those with suboptimal control of diabetes and hypertension, aligning with Healthcare Effectiveness Data and Information Set (HEDIS) measures.
- Medication management strategies were implemented, with utilization of technology tools encouraged.
Main Results:
- Most referred patients (Diabetes: 19/25, Hypertension: 45/70) presented with suboptimal disease control.
- Achievement of diabetes targets increased from 23% to 67% and hypertension targets from 29% to 58% following pharmacist interventions.
- Patients utilizing technology tools demonstrated a higher likelihood of reaching their therapeutic goals.
Conclusions:
- Pharmacist-physician collaboration significantly improves medication management and clinical outcomes in CKD patients.
- Technology integration enhances the effectiveness of collaborative drug therapy management, leading to better goal achievement.
- This model offers a valuable opportunity to improve the care of patients with Chronic Kidney Disease.
More Related Videos
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
116
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
116
01:18Chronic Kidney Disease IV: Nursing Management
87
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
87
01:20Acute Kidney Injury V: Interprofessional Care
68
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
68
01:29Chronic Pancreatitis II: Collaborative Care
141
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
141
01:24Chronic Kidney Disease II: Clinical Manifestations
157
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
157
01:25Chronic Kidney Disease I: Introduction
162
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
162